Jan 15, 2020 / 04:00PM GMT
Naomi Kumagai - JP Morgan Chase & Co, Research Division - Senior Analyst
Good morning, everyone. Welcome to the conference. My name is Naomi Kumagai, Japan pharma and med tech analyst at JPMorgan. It's my great pleasure to introduce Mr. Takeuchi, President and CEO of Olympus. Breakout will be in Georgian room. And with that, I'll turn it over to Mr. Takeuchi.
Yasuo Takeuchi - Olympus Corporation - President, CEO, Representative Executive Officer & Director
Thank you, Kumagai-san, for your kind introduction.
Today, I am privileged to be here for the first time as Olympus. Good morning, everyone. I am Yasuo Takeuchi, CEO and President of Olympus. Before jumping into main topic, I want to share a little bit of who I am. I am a pure breed of Olympus. This year marks my 40th anniversary working here, and took office last April. But half of my career was built outside of Japan, that gave me opportunities to look at my own company performance with eyes of outsider, and I have come to believe that Olympus has a potential for much stronger growth if we
Olympus Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot